144 related articles for article (PubMed ID: 33571504)
1. Pharmacological targeting of differential DNA repair, radio-sensitizes WRN-deficient cancer cells in vitro and in vivo.
Gupta P; Saha B; Chattopadhyay S; Patro BS
Biochem Pharmacol; 2021 Apr; 186():114450. PubMed ID: 33571504
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
Morgan MA; Parsels LA; Zhao L; Parsels JD; Davis MA; Hassan MC; Arumugarajah S; Hylander-Gans L; Morosini D; Simeone DM; Canman CE; Normolle DP; Zabludoff SD; Maybaum J; Lawrence TS
Cancer Res; 2010 Jun; 70(12):4972-81. PubMed ID: 20501833
[TBL] [Abstract][Full Text] [Related]
3. Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1.
Vance S; Liu E; Zhao L; Parsels JD; Parsels LA; Brown JL; Maybaum J; Lawrence TS; Morgan MA
Cell Cycle; 2011 Dec; 10(24):4321-9. PubMed ID: 22134241
[TBL] [Abstract][Full Text] [Related]
4. RAD51 and mitotic function of mus81 are essential for recovery from low-dose of camptothecin in the absence of the WRN exonuclease.
Aiello FA; Palma A; Malacaria E; Zheng L; Campbell JL; Shen B; Franchitto A; Pichierri P
Nucleic Acids Res; 2019 Jul; 47(13):6796-6810. PubMed ID: 31114910
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.
Engelke CG; Parsels LA; Qian Y; Zhang Q; Karnak D; Robertson JR; Tanska DM; Wei D; Davis MA; Parsels JD; Zhao L; Greenson JK; Lawrence TS; Maybaum J; Morgan MA
Clin Cancer Res; 2013 Aug; 19(16):4412-21. PubMed ID: 23804422
[TBL] [Abstract][Full Text] [Related]
7. WRN regulates pathway choice between classical and alternative non-homologous end joining.
Shamanna RA; Lu H; de Freitas JK; Tian J; Croteau DL; Bohr VA
Nat Commun; 2016 Dec; 7():13785. PubMed ID: 27922005
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
[TBL] [Abstract][Full Text] [Related]
9. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723
[TBL] [Abstract][Full Text] [Related]
10. Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.
Ferretti S; Hamon J; de Kanter R; Scheufler C; Andraos-Rey R; Barbe S; Bechter E; Blank J; Bordas V; Dammassa E; Decker A; Di Nanni N; Dourdoigne M; Gavioli E; Hattenberger M; Heuser A; Hemmerlin C; Hinrichs J; Kerr G; Laborde L; Jaco I; Núñez EJ; Martus HJ; Quadt C; Reschke M; Romanet V; Schaeffer F; Schoepfer J; Schrapp M; Strang R; Voshol H; Wartmann M; Welly S; Zécri F; Hofmann F; Möbitz H; Cortés-Cros M
Nature; 2024 May; 629(8011):443-449. PubMed ID: 38658754
[TBL] [Abstract][Full Text] [Related]
11. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair.
Chen L; Huang S; Lee L; Davalos A; Schiestl RH; Campisi J; Oshima J
Aging Cell; 2003 Aug; 2(4):191-9. PubMed ID: 12934712
[TBL] [Abstract][Full Text] [Related]
12. DNA end resection is needed for the repair of complex lesions in G1-phase human cells.
Averbeck NB; Ringel O; Herrlitz M; Jakob B; Durante M; Taucher-Scholz G
Cell Cycle; 2014; 13(16):2509-16. PubMed ID: 25486192
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).
Sommers JA; Kulikowicz T; Croteau DL; Dexheimer T; Dorjsuren D; Jadhav A; Maloney DJ; Simeonov A; Bohr VA; Brosh RM
PLoS One; 2019; 14(1):e0210525. PubMed ID: 30625228
[TBL] [Abstract][Full Text] [Related]
14. CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
Barker HE; Patel R; McLaughlin M; Schick U; Zaidi S; Nutting CM; Newbold KL; Bhide S; Harrington KJ
Mol Cancer Ther; 2016 Sep; 15(9):2042-54. PubMed ID: 27422809
[TBL] [Abstract][Full Text] [Related]
15. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
16. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation.
Wang X; Li GC; Iliakis G; Wang Y
Cancer Res; 2002 Nov; 62(21):6031-4. PubMed ID: 12414624
[TBL] [Abstract][Full Text] [Related]
17. CDK1 phosphorylates WRN at collapsed replication forks.
Palermo V; Rinalducci S; Sanchez M; Grillini F; Sommers JA; Brosh RM; Zolla L; Franchitto A; Pichierri P
Nat Commun; 2016 Sep; 7():12880. PubMed ID: 27634057
[TBL] [Abstract][Full Text] [Related]
18. CHK1 affecting cell radiosensitivity is independent of non-homologous end joining.
Wang H; Hu B; Liu R; Wang Y
Cell Cycle; 2005 Feb; 4(2):300-3. PubMed ID: 15655357
[TBL] [Abstract][Full Text] [Related]
19. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase.
Yannone SM; Roy S; Chan DW; Murphy MB; Huang S; Campisi J; Chen DJ
J Biol Chem; 2001 Oct; 276(41):38242-8. PubMed ID: 11477099
[TBL] [Abstract][Full Text] [Related]
20. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.
Sørensen CS; Hansen LT; Dziegielewski J; Syljuåsen RG; Lundin C; Bartek J; Helleday T
Nat Cell Biol; 2005 Feb; 7(2):195-201. PubMed ID: 15665856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
